News To sign up to our newsletter, complete this form To end your subscription, unsubscribe from this list 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 Biotech Sweden elects editorial councilDecember 14, 2009 Biotech Sweden, one of the Nordic countries most read news media, elects an editorial council. The council aims to act as advisors and gather information about everything that affects the life science industry. Among the elected is A+ Science CEO, Agneta Franksson. Read moreCME accreditation at the ESC congressSeptember 21, 2009 For the 6th consecutive year A+ Science has, in collaboration with the Sahlgrenska Academy at Gothenburg University, provided 3 accredited sessions of Continuing Medical Educations (CME). Read morePharmacovigilance launches 24 h MD servicesSeptember 01, 2009 Due to regulatory requirements all Marketing Authorization Holders are required to have access to a safety physician 24h a day. Read moreFörsöksläkemedel kan bevara insulinproduktion vid typ 1-diabetesJune 29, 2009 Patienter söks till en läkemedelsprövning av försöksläkemedlet Otelixizumab. Otelixizumab har i tidigare prövningar visat sig kunna bevara insulinproduktionen för patienter med tidig typ 1-diabetes i upp till 48 månader. Read moreNy VD utseddJune 19, 2009 In Swedish Read moreAgneta Franksson appointed New Managing DirectorJune 19, 2009 Agneta Franksson has been appointed Managing Director of A + Science AB, effective on May 25. Franksson will be located at the Stockholm office and will have a strong focus on sales and marketing. Read moreMeet us at Bio International Convention 2009April 02, 2009 May 18-21, 2009, Monday-Thursday Atlanta, GA USA Read moreDirect renin inhibitor Aliskiren as effective as LosartanFebruary 05, 2009 Results of the ALLAY* study, published in Circulation, shows that Aliskiren is as effective as Losartan in reducing LV mass. The follow-up (after 36 weeks) also showed that Aliskiren proved equally effective in lowering blood pressure. Read moreLedningsförändringFebruary 02, 2009 in Swedish Read moreCAFE-LLA study presents principal resultsJanuary 27, 2009 Results showed that favourable effects of Statins on cardiovascular outcomes in hypertensive patients are independent of large-artery function and central pressures. Read more